Phosphoinositide-3-Kinase Catalytic Alpha Polypeptide (PIK3Ca)

[Edit]

PI3K; P110α; p110-alpha; Phosphatidylinositol 4,5-bisphosphate 3-kinase 110 kDa catalytic subunit alpha; Serine/threonine protein kinase PIK3CA

Phosphoinositide-3-Kinase Catalytic Alpha Polypeptide (PIK3Ca)
The 85-kD subunit lacks PI3-kinase activity and acts as an adaptor, coupling the 110-kD subunit (p110) to activated protein tyrosine kinases. the cDNA for p110 predicts a 1,068-amino acid protein related to a protein which in S. cerevisiae is involved in the sorting of proteins to the vacuole. In COS-1 cells, p110 was catalytically active only when complexed with p85-alpha. PIP3, in turn, is required for translocation of protein kinase B (AKT1, PKB) to the cell membrane, where it is phosphorylated and activated by upstream kinases. The caspase-9-specific inhibitor ZVAD blocked PTEN-induced cell death without altering the effect of PTEN on cell cycle distribution. Overexpression of dominant-negative Akt induced more cell death but had less effect on the cell cycle than overexpression of PTEN.

Organism species: Homo sapiens (Human)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins RPJ830Hu01 Recombinant Phosphoinositide-3-Kinase Catalytic Alpha Polypeptide (PIK3Ca) Positive Control; Immunogen; SDS-PAGE; WB.
Antibodies n/a Monoclonal Antibody to Phosphoinositide-3-Kinase Catalytic Alpha Polypeptide (PIK3Ca) Monoclonal Antibody Customized Service Offer
n/a Polyclonal Antibody to Phosphoinositide-3-Kinase Catalytic Alpha Polypeptide (PIK3Ca) Polyclonal Antibody Customized Service Offer
Assay Kits SEJ830Hu ELISA Kit for Phosphoinositide-3-Kinase Catalytic Alpha Polypeptide (PIK3Ca) Enzyme-linked immunosorbent assay for Antigen Detection.

Organism species: Mus musculus (Mouse)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins n/a Recombinant Phosphoinositide-3-Kinase Catalytic Alpha Polypeptide (PIK3Ca) Recombinant Protein Customized Service Offer
Antibodies n/a Monoclonal Antibody to Phosphoinositide-3-Kinase Catalytic Alpha Polypeptide (PIK3Ca) Monoclonal Antibody Customized Service Offer
n/a Polyclonal Antibody to Phosphoinositide-3-Kinase Catalytic Alpha Polypeptide (PIK3Ca) Polyclonal Antibody Customized Service Offer
Assay Kits n/a CLIA Kit for Phosphoinositide-3-Kinase Catalytic Alpha Polypeptide (PIK3Ca) CLIA Kit Customized Service Offer
n/a ELISA Kit for Phosphoinositide-3-Kinase Catalytic Alpha Polypeptide (PIK3Ca) ELISA Kit Customized Service Offer

Organism species: Rattus norvegicus (Rat)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins n/a Recombinant Phosphoinositide-3-Kinase Catalytic Alpha Polypeptide (PIK3Ca) Recombinant Protein Customized Service Offer
Antibodies n/a Monoclonal Antibody to Phosphoinositide-3-Kinase Catalytic Alpha Polypeptide (PIK3Ca) Monoclonal Antibody Customized Service Offer
n/a Polyclonal Antibody to Phosphoinositide-3-Kinase Catalytic Alpha Polypeptide (PIK3Ca) Polyclonal Antibody Customized Service Offer
Assay Kits n/a CLIA Kit for Phosphoinositide-3-Kinase Catalytic Alpha Polypeptide (PIK3Ca) CLIA Kit Customized Service Offer
n/a ELISA Kit for Phosphoinositide-3-Kinase Catalytic Alpha Polypeptide (PIK3Ca) ELISA Kit Customized Service Offer
  1. "Molecular cloning, cDNA sequence, and chromosomal localization of the human phosphatidylinositol 3-kinase p110 alpha (PIK3CA) gene."Genomics 24:472-477(1994) [PubMed] [Europe PMC] [Abstract]
  2. "Cloning and mutagenesis of the p110 alpha subunit of human phosphoinositide 3'-hydroxykinase."Bioorg. Med. Chem. 5:65-74(1997) [PubMed] [Europe PMC] [Abstract]
  3. "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]
  4. "Identification of a chromosome 3p14.3-21.1 gene, APPL, encoding an adaptor molecule that interacts with the oncoprotein-serine/threonine kinase AKT2."Oncogene 18:4891-4898(1999) [PubMed] [Europe PMC] [Abstract]
  5. "Phosphoinositide 3-kinase signaling pathway mediated by p110{alpha} regulates invadopodia formation."J. Cell Biol. 193:1275-1288(2011) [PubMed] [Europe PMC] [Abstract]
  6. "Insights into the oncogenic effects of PIK3CA mutations from the structure of p110alpha/p85alpha."Cell Cycle 7:1151-1156(2008) [PubMed] [Europe PMC] [Abstract]
  7. "Class I PI3K in oncogenic cellular transformation."Oncogene 27:5486-5496(2008) [PubMed] [Europe PMC] [Abstract]
  8. "Should individual PI3 kinase isoforms be targeted in cancer?"Curr. Opin. Cell Biol. 21:199-208(2009) [PubMed] [Europe PMC] [Abstract]
  9. "The structure of a human p110alpha/p85alpha complex elucidates the effects of oncogenic PI3Kalpha mutations."Science 318:1744-1748(2007) [PubMed] [Europe PMC] [Abstract]
  10. "Solution structure of the C2 domain from human PI3-kinase p110 subunit alpha."Submitted (APR-2008) to the PDB data bank
  11. "A frequent kinase domain mutation that changes the interaction between PI3Kalpha and the membrane."Proc. Natl. Acad. Sci. U.S.A. 106:16996-17001(2009) [PubMed] [Europe PMC] [Abstract]
  12. "Mutations of PIK3CA in anaplastic oligodendrogliomas, high-grade astrocytomas, and medulloblastomas."Cancer Res. 64:5048-5050(2004) [PubMed] [Europe PMC] [Abstract]
  13. "Mutation of the PIK3CA gene in ovarian and breast cancer."Cancer Res. 64:7678-7681(2004) [PubMed] [Europe PMC] [Abstract]
  14. "High frequency of mutations of the PIK3CA gene in human cancers."Science 304:554-554(2004) [PubMed] [Europe PMC] [Abstract]
  15. "PIK3CA mutations in glioblastoma multiforme."Acta Neuropathol. 109:639-642(2005) [PubMed] [Europe PMC] [Abstract]
  16. "Mutations of PIK3CA in gastric adenocarcinoma."BMC Cancer 5:29-29(2005) [PubMed] [Europe PMC] [Abstract]
  17. "Functional analysis of PIK3CA gene mutations in human colorectal cancer."Cancer Res. 65:4562-4567(2005) [PubMed] [Europe PMC] [Abstract]
  18. "High frequency of coexistent mutations of PIK3CA and PTEN genes in endometrial carcinoma."Cancer Res. 65:10669-10673(2005) [PubMed] [Europe PMC] [Abstract]
  19. "The prevalence of PIK3CA mutations in gastric and colon cancer."Eur. J. Cancer 41:1649-1654(2005) [PubMed] [Europe PMC] [Abstract]
  20. "PIK3CA mutations in advanced ovarian carcinomas."Hum. Mutat. 25:322-322(2005) [PubMed] [Europe PMC] [Abstract]
  21. "PIK3CA gene is frequently mutated in breast carcinomas and hepatocellular carcinomas."Oncogene 24:1477-1480(2005) [PubMed] [Europe PMC] [Abstract]
  22. "PIK3CA mutations in head and neck squamous cell carcinoma."Clin. Cancer Res. 12:1441-1446(2006) [PubMed] [Europe PMC] [Abstract]
  23. "PIK3CA mutations in nasopharyngeal carcinoma."Int. J. Cancer 118:1065-1067(2006) [PubMed] [Europe PMC] [Abstract]
  24. "PIK3CA mutation and histological type in breast carcinoma: high frequency of mutations in lobular carcinoma."J. Pathol. 208:350-355(2006) [PubMed] [Europe PMC] [Abstract]
  25. "Cancer-specific mutations in PIK3CA are oncogenic in vivo."Proc. Natl. Acad. Sci. U.S.A. 103:1475-1479(2006) [PubMed] [Europe PMC] [Abstract]
  26. "Oncogenic PIK3CA mutations occur in epidermal nevi and seborrheic keratoses with a characteristic mutation pattern."Proc. Natl. Acad. Sci. U.S.A. 104:13450-13454(2007) [PubMed] [Europe PMC] [Abstract]
  27. "Somatic mosaic activating mutations in PIK3CA cause CLOVES syndrome."Am. J. Hum. Genet. 90:1108-1115(2012) [PubMed] [Europe PMC] [Abstract]
  28. "De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromes." Nat. Genet. 44:934-940(2012) [PubMed] [Europe PMC] [Abstract]
  29. "Germline PIK3CA and AKT1 mutations in Cowden and Cowden-like syndromes."Am. J. Hum. Genet. 92:76-80(2013) [PubMed] [Europe PMC] [Abstract]